34 results
Page 2 of 2
6-K
EX-99.2
c0z6cpm7 78p37k
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
6-K
EX-99.3
q8tjqy279dxo5vh1
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
F-1
ib7ncj0l0
9 Feb 24
Registration statement (foreign)
4:09pm
20-F
EX-4.8
aygnlh0ghwz w9zc54g
31 Jan 24
Annual report (foreign)
5:05pm
20-F
pl5p42vh d5
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.18
fuc8lh89
31 Jan 24
Annual report (foreign)
5:05pm
425
EX-10.1
eoy9r82coy
17 Jan 24
Business combination disclosure
6:00am
424B3
qujocvw3aoohcg903f
15 Nov 23
Prospectus supplement
4:28pm
F-4/A
zvgk9f
13 Nov 23
Registration of securities (foreign) (amended)
3:59pm
F-4/A
akil471psiewj jkf5zi
13 Nov 23
Registration of securities (foreign) (amended)
9:27am
F-4/A
otz25xq6m6qes8wl1hxt
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm
F-4/A
ngx3o31h
16 Oct 23
Registration of securities (foreign) (amended)
5:29pm
F-4/A
amgp 4welnkiw5iukxfx
20 Sep 23
Registration of securities (foreign) (amended)
5:26pm
F-4
orln0nq zvn26
31 Jul 23
Registration of securities (foreign)
9:55pm